Neurology
Vision Statement
To become a centre of excellence in neurological care, education, and research, committed to advancing innovation and compassionate patient care, shaping the future of neurology for the benefit of the community and beyond.
Mission Statement
Our mission is to deliver exceptional neurological care through advanced clinical services, innovative research, and comprehensive education, fostering collaboration and empathy to improve patient outcomes, enhance community health, and nurture the next generation of neurology professionals.
Faculty
| S. No. | Photo | Name & Qualification | Designation | Areas of Interest | |
|---|---|---|---|---|---|
| 1 |  |
Dr. Ashish Sharma MBBS (Gold Medalist), MD (Internal Medicine), DM Neurology (AIIMS New Delhi), MRCP (UK), FEBN, FEAN |
Additional Professor & Head | Neuro-Epidemiology, Neuro-Rehab with low cost tools & Technology, Stroke, MS & Other Demyelinating Disorders, Integrative Health (Yoga & Ayurveda), Clinical Trials (Academic & Regulatory) |
dr.ashish.neurology@aiimsbilaspur.edu.in |
| 2 |  |
Dr Neetika Sharma MBBS, MD (Internal Medicine), DM Neurology (PGIMER Chandigarh) |
Assistant Professor | Neuro-immunology, Movement Disorder, Neuromuscular Disorders |
dr.neetika.neurology@aiimsbilaspur.edu.in |
Services
IPD: A Block, 4th Floor, 28 Beds (15 + 13 Virtual Beds), MICU, Round the Clock Emergency Services.
OPD: B Block, 3rd Floor, Room No. 644/646, Thrice Weekly (Tuesday / Thursday / Saturday).
Tuesday / Thursday: 9:00 AM to 5:00 PM (Registration till 12 Noon)
Saturday: 9:00 AM to 1:00 PM (Registration till 11:00 AM)
Procedures (Diagnostic and/or Therapeutic)
| Specialized Diagnostic Services | Description | Workload / Week |
|---|---|---|
| EEG - OPD | 40-minute Electroencephalography in Neurology OPD Lab (648) | 15-20 / week |
| VEEG - IPD | Long Term Video EEG in Neurology IPD Area, A Block 4th Floor | 2-3 / week |
| PSG - IPD | PSG with AI Based Technology - Belun Ring & BRM (Started September 2023) | 2-3 / week |
| ENMG-EP (OPD) | NCS, EMG, RNST, EP’s, ERP’s, Single Fiber EMG in OPD Room 649 | 3-5 / daily |
Specialized Therapeutic Services
- Integrated Medicine with Evidence Based Yoga Modules for Migraine, Functional Neurological Disorders, Parkinson Disease and Epilepsy.
- Integrated Medicines with Evidence Based Ayurvedic Rehabilitative Treatment Plan for Acute Ischemic & Hemorrhagic Stroke in collaboration with Shiva Ayurvedic Medical College, Bilaspur (HP).
- Low-cost High-Tech Stroke Rehabilitation using tDCS device for home-based use after training in OPD/IPD.
- Stroke Hand Therapy Equipment / Mirror Therapy.
- Remote Electric Neuromodulation for acute migraine attack treatment and prophylaxis.
- Comprehensive Physical Therapy & Magnesium Hydrotherapy for Muscular Dystrophy patients in collaboration with Integrated Muscular Dystrophy Rehabilitation Centre, Solan (HP).
- Neuro-intervention in acute stroke patients in the form of Diagnostic DSA and Carotid Artery Stenting (CAS) in collaboration with Radiology Department.
- CDT (Aposan Infusion Pump) for Advanced Parkinson Disease through continuous dopaminergic therapy under APOSAN HOPE program.
- tDCS for postural and balance issues in Parkinson Disease patients in collaboration with iHub & HCI Foundation of IIT Mandi.
Teachings & Trainings
| S. No. | Name of the Course | Curriculum | Duration | Number of Students | Objectives / Brief Description of Course |
|---|---|---|---|---|---|
| 1 | Under-Graduate MBBS | Competency Based | All through duration of MBBS | 100 UG Students / Batch | Focusing on Neuro-Medicine. |
| 2 | Post-Graduate MD / MS | EPA-Based | Two Months Rotation | Academic Junior Residents | Super-specialty exposure in Neurology with Medicine, Pediatrics, Physiology and Psychiatry integration. |
| 3 | Post-Doctoral DM / PhD | EPA-Based | Three Years | Start from 01-07-25 | DM Neurology program and advanced doctoral research training. |
| 4 | Co-Guide (IIT Mandi) | Research Based | Three Years | Two | Collaborative interdisciplinary neurology research projects. |
| 5 | B.Sc Nursing (Hons) | Competency Based | Three Years | 40 per Batch | Neuromedicine related theory and practical training. |
| 6 | Paramedical Courses | Competency Based | Two Years | 20 per Batch | Neuromedicine related theory and practical training. |
Collaborative Research Projects:
- tDCS for postural & balance issues of Parkinson’s Disease patients in collaboration with iHub & HCI Foundation of IIT Mandi with Miss Pooja Sharma under Dr Shubhajit Roy Chowdhury, Associate Professor, SCEE, IIT Mandi.
- EEG-Based Parkinson’s Disease Data Analysis by Single & Dual Task Mechanism: In Collaboration with iHub & HCI foundation of IIT Mandi along with Faculty Fellow Dr Gaurav Jaswal of Dr Shubhajit Roy Chowdhury, Associate Professor, SCEE, IIT Mandi in collaboration with dept of Neurology AIIMS Bilaspur
Research
| S. No. | Title | Principal Investigator | Co-Investigator | Collaboration If Any (Department & Institute) | Funding Agency | Project Status |
|---|---|---|---|---|---|---|
| 1 | Fever, hyperglycemia, swallowing and hypertension management in acute stroke: A cluster randomized controlled trial (Indian Quality Improvement in Stroke Care study): SWG/Neuro/35/20 18-NCD-1 | Centre PI | - | Indian Stroke, Research Network, Intra-Institutional & National level | DHR | Ongoing |
| 2 | Blood Biobank stroke & controls/patient (FeSSH/InQuIST): DHR (No. SWG/Neuro/35/20 18-NCD-I) | Centre PI | - | Indian Stroke, Research, NetworkIntra-Institutional & National Level | DHR | Ongoing |
| 3 | Smartphone based Tele stroke Vs ‘Stroke Physician’ led Acute Stroke Management (SMART INDIA): A cluster randomized trial: File No. DHR- ICMR/GIA/04/18/2 020) | Centre PI | - | Intra- Institutional, National Level | DHR | Completed (Dec 2024) |
| 4 | Establishment of the Indian Stroke Clinical Trial Network Phase II (INSTRuCT Network Phase II): ICMR (No. SWG/Neuro/47/20 21-NCD-I) | Centre PI | - | ICMR-NCD, Task Force, Intra-Institutional & National Level | ICMR | Ongoing |
| 5 | Indian Trial of Tranexamic acid in Spontaneous intracerebral hemorrhage (INTRINSIC TRIAL) :No. SWG/Neuro/42/TF Centre II/2021- NCD-I | Centre PI | - | INSTRuCT Network, Intra-Institutional & National Level | ICMR | Ongoing |
| 6 | STENOSIS: Long term Single versus Dual Antiplatelet Therapy In Patients With Ischemic Stroke due to Intracranial Atherosclerotic Disease: A Randomized Trial.: No. SWG/Neuro/41/20 21-NCD-I | Centre PI | - | INSTRuCT Network, Intra-Institutional & National Level | ICMR | Ongoing |
| 7 | Development of Hospital Based Stroke Registries (HBSR) under National Stroke Registry Programme of ICMR-NCDIR, Bengaluru: No. NCDIR/HBSR/40/20 21/2737 Dated 4-1- 22 | Centre PI | - | Multi-Center Registry under NCDIR Bengaluru Intra- Institutional & National Level | ICMR-NCDIR | Ongoing |
| 8 | PROLEVIS (Two projects: Ischemic Stroke & Hemorrhagic stroke): DST(SERB), GOI, (ECR/2017/000174 | Centre PI | - | Multi-center National Trial under AIIMS New Delhi | DST-SERB | Ongoing |
| 9 | PROLEVIS CVT (Two projects: Primary Prevention & Secondary Prevention): DST(SERB), GOI, (ECR/2017/000175) | Centre PI | - | Multi-center Trial National under AIIMS New Delhi | DST-SERB | Ongoing |
| 10 | Indian Multiple Slerosis and Allied Demyelinating Disorders Registry and Research Network." :5/4- 5/192/Neuro/TF Centre I/2019-NCD- I Dated 16-01-23 | Centre PI | - | IMSRN, Intra- Institutional & National Level | ICMR | Ongoing |
| 11 | Comprehensive genetic analysis of PD patients in India | Center PI | - | Muti-center National Trial | - | Completed September 24 |
| 12 | A Cross Sectional Study of Neurophysiological & Biochemical parameters in Hypothyroid Patients of Hilly region of Himachal Pradesh: ICMR vide notification number BMI/e-PMS/Adhoc & fellowships/2021/0 2 Dated 28-3-22 | - | Co-Investigator | Inter-Institutional | ICMR | Ongoing |
| 13 | Deciphering molecular efficacy of repetitive transcranial magnetic stimulaiton (rTMS) in treating dementia in low vs Himalayan high- landers | - | Co-Investigator | Inter-Institutional | DST-SERB | In Abeyanc e Due to Non- Availabili ty of TMS till now |
| 14 | Comparative Retrospective Study on Betahistine +Maneuvers vs. Maneuvers Only in the Management of Benign Paroxysmal Positional Vertigo (BPPV) | PI | - | Inter-Institutional | Unfunded investi gator- initiate d project s | Completed |
| 15 | Autonomic Function Test’s in Parkinson Disease, Diabetes Mellitus & Migraine patients (Three Projects) | PI | - | Inter-Institutional | Unfunded investi gator- initiate d project s | Ongoing |
| 16 | Yoga Modules in Migraine, Parkinson Disease & Functional Neurological Disorders (Three Projects) | PI | - | Inter-Institutional | Unfunded investi gator- initiate d project s | Ongoing |
| 17 | An investigator initiated, retrospective analysis to evaluate the efficacy and safety of Remote Electric Neuromodulation (REN), via neuromodulation device Nerivio™, for the acute and preventive treatment of migraine Two Projects | PI | - | Inter-Institutional | Unfunded investi gator- initiate d project s | Ongoing |
| 18 | “Comprehensive Genetic Analysis of Parkinson’s Disease with Juvenile onset/young onset with ≤50yrs of onset in sub- Himalayan population of North-western part of India” | PI | - | Inter-Institutional | - | Ongoing |
Expansion Plan
| S. No. | Collaboration For | Collaboration with Department / Institute | Services Offered / Work Undergoing in Collaboration |
|---|---|---|---|
| 1 | Efficacy and safety of Nerivio™, a remote electrical neuromodulation device, for prophylaxis of episodic and chronic migraine: an open label, multicentric study in Indian population | Extramural (Pharma Sponsored) / Interventional trial/Phase 4 study, Dr. Reddy’s Lab | Submitted to IEC-CT |
| 2 | Efficacy and safety of Nerivio™, a remote electrical neuromodulation device, for the acute treatment of episodic and chronic migraine: an open label, multicentric study in Indian population | Extramural (Pharma Sponsored) / Interventional trial/Phase 4 study, Dr. Reddy’s Lab | Submitted to IEC-CT |
| 3 | A prospective, multicentric, randomized, double-blind, parallel, phase IV study to assess the safety and efficacy of TycamzziTM (Sovateltide) in patients with acute cerebral ischemic stroke | Extramural Interventional trial/Pharma Sponsored-Pharmazz India Pvt. Ltd. | Submitted to IEC-CT |
| 4 | Ayurvedic Rehabilitative treatment in addition to Conventional Allopathic Rehabilitation treatment in stroke patients: A single blinded randomized controlled Trial with blinded assessment (PROBE Design) | Intramural funding will be sought after EC Clearance | Currently Submitted to IEC (BHR) for approval |
| 5 | Replication cohort for refining and validating findings from the Phase I of the Genetic Architecture of Parkinson’s disease (GAP) -India study | Global Parkinson's Genetic Program managed by Fox foundation | Currently Submitted to ISAC for approval |
| 6 | A Phase 3, Randomized, Double-Blind, Parallel Group, Placebo- Controlled Study to Demonstrate the Efficacy and Safety of an Oral Factor XIa Inhibitor Milvexian, for Stroke Prevention after an Acute Ischemic Stroke or High Risk Transient Ischemic Attack | Joint collaboration between IQVIA, Bristol-Myers Squibb, and Janssen R&D, Extramural (Pharma Sponsored) / Interventional trial/Phase 3 study | Submitted to CTRC |
| 7 | A prospective, multi- Centre, randomized, parallel group, two-arm, active control, open label, clinical study to evaluate efficacy and safety of Tenecteplase /R-TPR-012 (0.25 mg/kg) compared with Tenectase™ (0.20 mg/kg) in patients with Acute Ischemic stroke | Reliance Life Sciences Pvt. Ltd., Extramural (Pharma Sponsored) / Interventional trial/Phase 3 study | SQV is over. EC Dossier awaited. |
| 8 | “Development of a Duchenne Muscular Dystrophy Registry to optimize care”: | In Association with Indian Association of Muscular Dystrophy & IMDRC Solani | Currently submitted to ISAC for approval |
| 9 | A multi-faCtorial, mulTi- arm, multi-staGe, randomised, gLOBal Adaptive pLatform trial for stroke (ACT-GLOBAL), Academic Global Trials The ACT-GLOBAL study aims to identify the treatment/s associated with the highest chance of improving outcome, i.e., modified Rankin Scale, at 90 days after stroke onset, in adults after hospitalization. The ACT GLOBAL has 2 domains at present: 1. Blood Pressure Domain SQV is over. EC Dossier awaited. Extramural (Pharma Sponsored) / Interventional trial/Phase 3 study(ENCHANTED3/MT) 2. Thrombolysis Domain (ACT- WHEN) | The study is sponsored by the University of Calgary, Canada, and The George Institute for Global Health, Australia. In India, the study will be coordinated by Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum (PI: Dr Sylaja P N), and Christian Medical College, Ludhiana (PI: Dr Jeyaraj D Pandian). | Sub-site Agreement submitted for signatures of the ED via Dean Research |
| 10 | Reducing the Burden of Cardiovascular Events with Antiplatelet Therapy in Patients with Intracerebral Haemorrhage: BEAT-ICH India | Department of Neurology, Christian Medical College and Hospital Ludhiana: National Coordinating Centre | SQV is over. EC Dossier awaited. |
| 11 | Impact of Vedic Chants Intervention Program(VCIP) in children with Autism Spectrum Disorders (ASD). | Midam Foundation, Puducherry & Chetna Rehabilitation & Research Center, Bilaspur(HP) | Currently submitted to ISAC for approval |
| 12 | A randomized, double- blind, parallel-group study to compare the pharmacokinetics, efficacy, pharmacodynamics, safety, and immunogenicity of CYB704 (proposed ocrelizumab biosimilar) and Ocrevus® (EU- authorized and US- licensed) in participants with relapsing multiple sclerosis (RMS). | Pharma Sponsored(Sandoz) in cooperation with PSI CRO Phase 3 study | SQV is over. EC Dossier awaited. |
22/04/2026 13:01:24
Important Website Links
